Cart
sales@molnova.com
Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)
CAS No. 93965-89-0
Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)( ——— )
Catalog No. M41195 CAS No. 93965-89-0
[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAc-[Tyr1,D-Phe2]-GRF (1-29) amide (human)
-
NoteResearch use only, not for human use.
-
Brief Description[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
-
Description[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
-
In VitroCell Proliferation Assay Cell Line:C6 rat glioblastoma cells Concentration:0.1 pM-10 nM Incubation Time:3 days Result:Induced a dose-dependent cell proliferation increase.
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorVIP
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number93965-89-0
-
Formula Weight3476.09
-
Molecular FormulaC157H252N44O43S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Waelbroeck M, et al. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology. 1985 Jun;116(6):2643-9.?
molnova catalog
related products
-
PF-06446846
PF?06446846 is a potent and selective PCSK9 inhibitor?PF-06446846 reduces plasma PCSK9 and total cholesterol levels in rats following oral dosing.?
-
3-Hydroxyniazinin
3-Hydroxyniazinin
-
K03861
K03861 is a type II CDK2 inhibitor with Kd of 50 nM, 18.6 nM, 15.4 nM, and 9.7 nM for CDK2(WT), CDK2(C118L), CDK2(A144C), and CDK2(C118L/A144C), respectlvely.
